Trusted Resources

Jun 01, 2022

Guidelines and New Directions in the Therapy and Monitoring of ATTRv Amyloidosis

Read more

May 17, 2022

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Read more

Mar 22, 2022

RNA-Targeting and Gene Editing Therapies for Transthyretin Amyloidosis

Read more

Mar 16, 2022

How Did Transthyretin Amyloid Cardiomyopathy Progress in Patients Who Took Placebo in the Study ATTR-ACT? A Plain Language Summary

Read more

Feb 08, 2022

Bone Marrow Amyloid: A Comprehensive Analysis of 1,469 Samples, Including Amyloid Type, Clinical Features, and Morphologic Distribution

Read more

Feb 03, 2022

Genetic Testing and Counseling for hATTR Amyloidosis

Read more

Feb 01, 2022

Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis

Read more

Jan 31, 2022

Living With Amyloidosis

Read more

Jan 31, 2022

Summary of the EHA-ISA Working Group Guidelines for High-Dose Chemotherapy and Stem Cell Transplantation for Systemic AL Amyloidosis

Read more

Dec 19, 2021

Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy

Background: Tafamidis is approved in many countries for the treatment of transthyretin amyloid cardiomyopathy. This study reports data on the long-term efficacy of…

Read more

Subscribe to